Literature DB >> 29456483

Two Novel Pathogenic MID1 Variants and Genotype-Phenotype Correlation Reanalysis in X-Linked Opitz G/BBB Syndrome.

Nuno Maia1,2, Maria J Nabais Sá3,2, Nataliya Tkachenko3, Gabriela Soares3, Isabel Marques1,2, Bárbara Rodrigues1,2,4, Ana M Fortuna3,2, Rosário Santos1,2, Arjan P M de Brouwer5, Paula Jorge1,2.   

Abstract

X-linked Opitz G/BBB syndrome (XLOS) is a multisystemic congenital condition, caused by mutations in the midline-1 gene (MID1), characterized by a large inter- and intrafamilial phenotypic variability and often associated with intellectual disability (ID). We report clinical, genetic, and molecular findings in 4 patients with typical XLOS dysmorphic features belonging to 2 unrelated families. Two novel pathogenic loss-of-function MID1 variants, a maternally inherited c.1656del and a de novo c.1215_1228dup, were identified. Subsequently, we performed a genotype-phenotype analysis using data from 91 male XLOS patients. To test the mutation impact on the phenotype; the type of mutation, the MID1-impaired domain and function were compared with the presence of each of the major clinical features (hypertelorism, clefts of the lip and/or palate, laryngo-tracheo-esophageal abnormalities, hypospadias and ID) and minor clinical features (brain, heart, and anal defects). No statistically significant correlation was found with these features. Further investigations, as well as exhaustive and unequivocal phenotyping, may be required to improve our knowledge of the biological mechanisms underlying this syndrome and to provide more adequate disease management.

Entities:  

Keywords:  Genotype-phenotype correlation; MID1 pathogenic variants; X-linked Opitz G/BBB syndrome

Year:  2017        PMID: 29456483      PMCID: PMC5803688          DOI: 10.1159/000479177

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  35 in total

1.  MID1 mutations in patients with X-linked Opitz G/BBB syndrome.

Authors:  Bianca Fontanella; Giorgio Russolillo; Germana Meroni
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

2.  Opitz syndrome is genetically heterogeneous, with one locus on Xp22, and a second locus on 22q11.2.

Authors:  N H Robin; G J Feldman; A L Aronson; H F Mitchell; R Weksberg; C O Leonard; B K Burton; K D Josephson; R Laxová; K A Aleck; J E Allanson; M L Guion-Almeida; R A Martin; L G Leichtman; R A Price; J M Opitz; M Muenke
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

3.  Complex rearrangement of the exon 6 genomic region among Opitz G/BBB Syndrome MID1 alterations.

Authors:  Chiara Migliore; Emmanouil Athanasakis; Sophie Dahoun; Ambroise Wonkam; Melissa Lees; Olga Calabrese; Fiona Connell; Sally Ann Lynch; Claudia Izzi; Eva Pompilii; Seema Thakur; Merel van Maarle; Louise C Wilson; Germana Meroni
Journal:  Eur J Med Genet       Date:  2013-06-19       Impact factor: 2.708

4.  The Opitz syndrome gene product, MID1, associates with microtubules.

Authors:  S Schweiger; J Foerster; T Lehmann; V Suckow; Y A Muller; G Walter; T Davies; H Porter; H van Bokhoven; P W Lunt; P Traub; H H Ropers
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Hypospadias associated with hypertelorism, the mildest phenotype of Opitz syndrome.

Authors:  Xufeng Zhang; Yougen Chen; Shentiang Zhao; Ellen Markljung; Agneta Nordenskjöld
Journal:  J Hum Genet       Date:  2011-02-17       Impact factor: 3.172

6.  Mutations in SPECC1L, encoding sperm antigen with calponin homology and coiled-coil domains 1-like, are found in some cases of autosomal dominant Opitz G/BBB syndrome.

Authors:  Paul Kruszka; Dong Li; Margaret H Harr; Nathan R Wilson; Daniel Swarr; Elizabeth M McCormick; Rosetta M Chiavacci; Mindy Li; Ariel F Martinez; Rachel A Hart; Donna M McDonald-McGinn; Matthew A Deardorff; Marni J Falk; Judith E Allanson; Cindy Hudson; John P Johnson; Irfan Saadi; Hakon Hakonarson; Maximilian Muenke; Elaine H Zackai
Journal:  J Med Genet       Date:  2014-11-20       Impact factor: 6.318

7.  Exon 2 duplication of the MID1 gene in a patient with a mild phenotype of Opitz G/BBB syndrome.

Authors:  Irina Hüning; Kerstin Kutsche; Saideh Rajaei; Anna Erlandsson; Lovisa Lovmar; Julia Rundberg; Margarita Stefanova
Journal:  Eur J Med Genet       Date:  2013-01-23       Impact factor: 2.708

8.  Duplication of the MID1 first exon in a patient with Opitz G/BBB syndrome.

Authors:  Jennifer Winter; Tanja Lehmann; Vanessa Suckow; Zofia Kijas; Andreas Kulozik; Vera Kalscheuer; Ben Hamel; Koen Devriendt; John Opitz; Steffen Lenzner; Hans-Hilger Ropers; Susann Schweiger
Journal:  Hum Genet       Date:  2003-01-24       Impact factor: 4.132

9.  Opitz G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-terminal domain.

Authors:  K Gaudenz; E Roessler; N Quaderi; B Franco; G Feldman; D L Gasser; B Wittwer; J Horst; E Montini; J M Opitz; A Ballabio; M Muenke
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

10.  MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.

Authors:  Haijuan Du; Kuanlin Wu; Alma Didoronkute; Marcus V A Levy; Nimish Todi; Anna Shchelokova; Michael A Massiah
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

View more
  2 in total

1.  Clinical lesson learned from genetic analysis in patients prior to surgical repair of hypospadias.

Authors:  Nurin A Listyasari; Gorjana Robevska; Katie L Ayers; Tiong Yang Tan; Andrew H Sinclair; Sultana M H Faradz
Journal:  Asian J Urol       Date:  2022-03-01

2.  Characterization With Gene Mutations in Han Chinese Patients With Hypospadias and Function Analysis of a Novel AR Genevariant.

Authors:  Lifen Chen; Junqi Wang; Wenli Lu; Yuan Xiao; Jihong Ni; Wei Wang; Xiaoyu Ma; Zhiya Dong
Journal:  Front Genet       Date:  2021-06-30       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.